Covered recipient · General Payments record
MOHAMAD HASSAN BAZZI
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$2,579.11
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $293.40 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $61.58 | 3 |
| Kerecis Limited | $54.20 | 2 |
| Smith & Nephew, Inc. | $53.04 | 3 |
| Solventum Corporation | $50.24 | 3 |
| ABBVIE INC. | $22.76 | 1 |
| ORGANOGENESIS INC. | $22.63 | 1 |
| Integra LifeSciences Corporation | $15.17 | 1 |
| AVITA MEDICAL AMERICAS, LLC | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.76 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103294423 | CMS |
| Avita Medical Americas, Llc | $13.78 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126200706 | CMS |
| Integra LifeSciences Corporation | $15.17 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140120464 | CMS |
| Kerecis Limited | $46.80 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120121653 | CMS |
| Kerecis Limited | $7.40 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120121655 | CMS |
| MIMEDX Group, Inc. | $15.65 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255113 | CMS |
| MIMEDX Group, Inc. | $30.49 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255115 | CMS |
| MIMEDX Group, Inc. | $15.44 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255117 | CMS |
| Organogenesis Inc. | $22.63 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145419121 | CMS |
| Smith+Nephew, Inc. | $19.56 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149490783 | CMS |
| Smith+Nephew, Inc. | $19.18 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149490781 | CMS |
| Smith+Nephew, Inc. | $14.30 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149490779 | CMS |
| Solventum Corporation | $18.77 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144064420 | CMS |
| Solventum Corporation | $17.57 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144064422 | CMS |
| Solventum Corporation | $13.90 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144064424 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.